Curaxis neurology news

Curaxis announced that its board is exploring financial and strategic alternatives. The company said a majority of its executive officers and directors have recently resigned and new board members have been appointed. At June 30, the company had $9,000 in cash and a six-month operating loss of $1.1 million. ...